by its ligand results in transduction of a signal for cell death. The Fas system has been implicated in target cell recognition, clonal development of immune effector cells, and termination of the cellular immune response. Fas antigen expression on lymphocytes is regulated by interferon y (IFNy) and tumor necrosis factor a (TNFa), cytokines that also have inhibitory effects on hematopoiesis. We investigated Fas antigen expression on human marrow cells and the effects of Fas activation on hematopoiesis in vitro. Freshly isolated immature hematopoietic cells, as defined by the CD34 marker, did not express Fas antigen at levels detectable by fluorescent staining. CD34+ cells, which include progenitors and stem cells, showed low levels of Fas expression in culture, even in the presence of growth factors. Stimulation by TNFa and IFNy markedly increased Fas antigen expression on CD34+ cells. Anti-Fas antibody, which mimics the action AS ANTIGEN (CD95) is a novel member of the nerve growth factor receptor/tumor necrosis factor (TNF) receptor Triggering of the Fas receptor pathway by its ligand or specific monoclonal antibody (MoAb) results in apoptosis of susceptible normal and malignant cells of lymphoid origin by a calcium-independent pathway.'"' Fas ligand is a molecule functionally related to TNFa, TNFP, and interferon y (IFNY).~ Fas antigen and its ligand have been related to the normal regulation of T-and B-cell development; Fas is expressed on activated T and B cells." Fas antigen is also involved in the cytotoxic T-cell response'0,12,13 and appears to be the major target for helper lymphototoxicity. Fas expression has been high on some morphologically or immunophenotypically defined cell subpopulations in peripheral blood'' and lymph nodes,I7 in some lymphomas'." and acute T-lymphocytic leukemia.I8 Mice homozygous for either the Zpr or gld genes have autoimmune disease characterized by lymphadenopathy, accumulation of CD4-/ CDS-T cells in the blood, hyperimmunoglobulinemia, autoantibodies, and renal disease; l p r is the result of insertion of a transposable retroviral element into the Fas and gld of mutation in the Fas-ligand Parallel to these observations in mice, soluble Fas ligand was found to be increased in the blood of patients with systemic lupus erythematosus.8
Fas expression and Fas-mediated cytotoxicity is greatly increased on target cells by treatment with IFNY.'.'~-~~ Cytokines such as TNFa and IFNy act on hematopoietic cells as well as lympho~ytes.~~.~* Under a variety of cell culture conditions, IFNyz9.'" and T N F C~~" .~' inhibit hematopoietic cell growth, although in some in vitro circumstances, these same molecules may be ~timulatory.~~ In animal models33 and treated human patient^:^.^' their dominant effect appears to be suppressive of normal hematopoiesis. IFNy36.40 and TNFCX~.~' have also been implicated in bone marrow (BM) failure syndromes. We speculated that the inhibitory effects of TNFa and IFNy on hematopoiesis might be mediated or potentiated by the Fas receptor/Fas ligand system. We investigated both Fas expression on hematopoietic cells and the consequences of activation of this receptor on marrow cell proliferation in vitro. After I week o f culture at 37°C. the incubator temperature was changed to W C . Media changes were performed weekly. Nonadherent cells were removed from the dishes. washed. and counted: half the cells were returned t o the original dishes. and the other half used in replating experiments to measure the output of clonogenic progenitors. TNFn. IFNy. and anti-Fas MoAh were added weekly at appropriate concentrations. After S weeks of culture. nonadherent cells were procured using trypsin solution (GIBCO).
washed. and replated in methylcellulose to estimate the numbers of Ion, <'-term culture initiating cells (LTCIC). The numher of clonogenic cells was convened to the ahsolute numher of LTCIC hy dividing hy 4 . ' " . ' "
Hematopoietic progenitors were measured in methylcellulose cultures. Freshly isolated or previously cultured BM cells were plated in methylcellulose in the presence of SO nglmL IL-3 (Genzyme. Boston MA). 2 0 ng/mL granulocyte-macrophage colony-stimulating factor (GM-CSF; Boehringer). SO ng/mL stem cell factor (SCF). and 2 UlmL EPO. Total BM cells were plated at a density of I X IO' cells in I mL o f culture medium in 35-mm dishes. CD34-cells were plated at ;I density of I X IO' cells/O.S mL methylcellulose in 48-well. I I-mm plates. TNFn. IFNy. and anti-Fas MoAh were added to the culture at appropriate concentrations. All cultures were performed in duplicate. Experimental procedures were performed in endotoxin-free plasticware. and levels o f endotoxin contamination of cytokine preparations were <O. I3 endotoxin Ulmg by the limulus wsay. according t o the manufacturers' specilications. Antihodies used in a l l experiments contained less than I ng/mL of endotoxin.
For control experiments for flow cytonletry and tissue culture experiments. isotypic MoAh were used (Dako. Cnrpinteria CA).
Ap0plo.si.Y tr.s.scr~.s. DNA fragmentation was measured after extraction of low molecular-weight DNA. Two X IO" cells were xuspended in 900 pL 1 X TRIS-EDTA huffer and lysed with 2S pL 30% sodium dodecyl sulfate.J7 High-molecular-weight DNA was precipitated fnr 6 hours in the presence of 5 molL NaCI. The high molecul;w-weight fraction was pelleted hy high-speed centrifugation. and the fragmented DNA was extracted from the aqueous phase with phenol and chloroform and precipitated with ethanol. After resuspension in water. DNA was electrophoresed using I .S% agarose gel and visualized hy ethidium hromide staining.
To quantitate the number of cells undergoing apoptosis. cells were fixed with 4% neutntl huffered formalin and cytoccntrifugcd onto siliconized slides. Apoptotic cells were stained using the terminal deoxytransferase method (Apotag: Oncor. Gaithcrshurg MD). Endogenous peroxidase was lirst quenched with 05%-hydrogen peroxide and the cells were permeahilized using company-supplied cquilihration buffer. The 3'-OH ends o f tlegrnded DNA were reacted with terminal deoxynuclcotidyl transferase (TdT) and digoxigenin-labeled adenosine triposphatc for 30 minutes. After washing with PBS. slides were reacted with an anti-digoxigenin MoAh conjugated to peroxidase. washed and developed with 3.3' di;lminohcnzitline tctruhydrochroride (Pierce. Rocklord. IL). Stained cells were counted using a light microscope. For Values represent percentage t SD of control samples. A total of two experiments were performed with total BM cells and four experiments with purified CD34' cells. In each experiment, all cultures were performed in duplicate. Mean absolute number of colonies in the controls was 308 t 24 erythroid and 125 2 13 for myeloid colonies (per lo5 cells) for total B M and 57 t 3 erythroid and 38 2 7 meyloid colonies (per lo3 cells) for purified CD34' cells. TNFa was used at the concentration of 10 ng/mL and IFNy at the concentration of 1,000 U/mL. Anti-Fas MoAb was used at the concentration of 0.5 pg/mL. Abbreviation: ery, erythroid: rnyelo, myeloid. rescence intensity) were detected when purified CD34' cells were cultured in the presence of TNFa or IFNy or the two cytokines together (Fig I , Table l) . Similar results were observed for CD34' cells when total BM cells were cultured in the absence of growth factors; IFNy and TNFa also increased Fas expression on CD34+ in these cultures with or without added hematopoietic growth factors (data not shown).
RESULTS

Expressiorl
The expression of CD95 on CD34' cells was maximal at 48 hours of culture and required concentrations of TNFa 2 10 ng/mL and IFNy 2 1,000 U/mL (Fig 2) . Higher concentrations of these factors resulted in major loss of cell viability; at the lower concentrations used, cell death, as determined by trypan blue exclusion, was <15%. The strongest induction of Fas antigen expression was observed in the presence of both IFNy and TNFa (Table I) , but observations over a wide range of IFNy and TNFa concentrations suggested an additive rather than synergistic effect (Fig 2) .
Inhibition of hematopoietic colony formation by anti-Fas MoAb. As IFNy and TNFa stimulated expression of CD95 ' BM cells, we tested whether treatment with a specific MoAb to Fas antigen, known to mimic the action of natural Fas would influence hematopoietic colony formation by total BM cells. Total erythroid and myeloid colonies were determined after 14 days in standard clonogenic assays. Anti-Fas MoAb alone had minimal effect on colony formation (Fig 3) . When either total BM cells or purified CD34+ cells were cultured in the presence of antibody and concentrations of TNFa or IFNy known to result in approximately 50% inhibition of colony formation, anti-Fas antibody greatly potentiated these inhibitory effects (Fig 3; Table  2 ). A second anti-Fas MoAb, which blocks Fas ligand activati or^,'.^* did not potentiate the action of IFNy or TNFa (Fig 3) .
Activating Fas antibody-mediated inhibition of colony formation was dose dependent as measured by inhibition of colony formation by CD34+ cells in the presence of suboptimal concentrations of IFNy and TNFa (Fig 4) . Binding of Fas antigen by the activating MoAb enhanced inhibition of colony formation by very low concentrations of IFNy (20 U/mL) and TNFa (0.2 ng/mL), which ordinarily do not result in significant hematosuppression in vitro (Fig 4) . 
Anti-Fas MoAb p g h L
For personal use only. on April 14, 2017. by guest www.bloodjournal.org From Values represent mean -c SD of two independent experiments. IFNy and TNFn were added to the culture weekly at concentrations of 1,000 U/mL and 10 ng/mL, respectively. Anti-Fas MoAb was used at 0.5 pg/mL. Statistical analysis (paired t-test): BM cells: control versus IFNy. P < .01; control versus TNFn, P < .01; IFNy versus IFNy + anti-Fas. P < .01; TNFa versus TNFn + anti-Fas, P .01; CD34' cells: control versus IFNy, P < .01; control versus TNFn, P .01; IFNy versus IFNy + anti-Fas, P < .05; TNFn versus TNFn + anti-Fas, P .05.
From CD34' cells cultured on allogeneic stroma
We also tested whether the effect of anti-Fas MoAb was limited to a more mature subpopulation of CD34' cells, as dcfined by the expression of the CD38 antigen.'"' Equivalent enhancement of the inhibitory action of I F F Y and TNFa by anti-Fas MoAb was observed for both committed CD34' CD38' cells and more immature CD34'CD38 cells. and again only a modest effect of anti-Fas MoAb alone was observed for cultures not treated with TNFa or IFNy (data not shown).
Effect ofmti-Fm MoAI7 on LTCICs. Because anti-Fas antibody enhanced the inhibition by IFNy and TNFa of colony formation from CD34' cells. we tested whether very immature hematopoietic cells, defined by their ability to form colonies after S weeks of suspension culture (also referred to as LTCIC). were suppressed by triggering of Fas-receptor. In long-term cultures. activating anti-Fas MoAb alone did not affect the generation or maintenance of LTCIC: however. it much augmented the negative effects of lFNy and TNFa on both the generation of LTCIC and on stroma formation in LTBMC (Table 3) . Similar results were obtained when highly purified CD34' cells were seeded onto preformed irradiated allogeneic stroma and cultured for S weeks under LTBMC conditions. Anti-Fas MoAb alone showed only a modest effect on LTCIC generation but potentiated the inhibitory effects of lFNy and TNFa on the numbers of LTCIC generated (Table 3) .
Ability of mrti-Fm MoAh t o medicrte upoptosis of BM cells Enhanced inhibition of colony formation by anti-Fas MoAb also might be caused by induction of cell death of clonogenic progenitors. To test this hypothesis. we stimulated total BM cells with IFNy and TNFa (at suboptimal concentrations that induced minimal apoptosis) in the presence and absence of anti-Fas antibody. Low molecular-weight DNA extracted from constant numbers of these cells cultured with anti-Fas MoAb showed a nucleosomal degradation pattern typical of apoptosis ( Fig  SA) . To determine whether anti-Fas MoAb-mediated apoptosis of hematopoietic progenitor cells, we visualized the nucleosomal ladder by electrophoresis of low molecular weight DNA extracted from purified CD34' cells ( I O " cells per extraction) stimulated with IFNy or TNFa (Fig SB) . We also measured the number of apoptotic cells in cultures of CD34' cells stimulated with anti-Fas MoAb in the presence of these cytokines using an in situ assay (Fig SC) . Anti-Fas MoAb increased the number of CD34' cells in apoptosis in cultures containing negative cytokines.
DISCUSSION
We have detected Fas antigen on human hematopoietic cells cultured in vitro. Most of our studies were performed with a purified population of marrow cells selected for ex- As with lymphocytes, on hematopoietic cells Fas antigen stimulation was correlated with the induction of apoptosis in the CD34' population.
Thus, induction of Fas antigen expression by TNFa and IFNy wound render the cells susceptible to Fas ligand-(or anti-Fas MoAb)-mediated apoptosis. This cooperative action of inhibitory cytokines may account for their synergistic inhibitory effect on hematopoietic cell proliferation in vitro. Suppression of colony formation likely results in this setting at least in part because of the killing of clonogenic progenitors. Our results, of course, do not exclude other mechanisms of apoptotic cell death independent of Fas antigen stimulation. Indeed, we observed a more profound effect of anti-Fas MoAb on colony formation than on CD34' cell viability. Fas might have been selectively induced on colony-forming cells, induced on progeny cells during differentiation in vitro or, alternatively, cell proliferation was suppressed independent of cell death. Thus, hematopoietic suppression after stimulation of Fas may be caused by mechanisms other than apoptosis, such as metabolic disturbances or a block in cell cycle progression. Recently, hcl-2 has been shown to prevent Fas-mediated cell death," and upregulation of this protein because of growth factor stimulation might protect hematopoietic progenitors from killing, even if they were unable to enter cell cycle. Whether Fas represents a final pathway for programmed cell death induced by inhibitory cytokines or Fas ligand cooperates synergistically with IFNy and TNFa is the subject of current experiments.
In the presence of anti-Fas MoAb and either IFNy or TNFa, the very marked reduction in hematopoiesis in vitro.
as observed in direct clonogenic assays and in the LTCIC system extended from mature progenitor cells to cells considered surrogates for true stem cells. Although extrapolation from tissue culture to disease pathophysiology should be undertaken cautiously, cooperation among several coregulated inhibitory cytokines-IFNy, TNFa, and Fas ligandwould exert a potent negative effect on marrow cells in the setting of immune-system attack. As with IFNy and TNFa, expression of Fas has been associated with viral infection (on the lymphocytes of patients with adult T-cell leukemia,"." on cells from children infected with the human immunodeficiency virus,s4 and in the liver of patients with chronic hepatitis C infection"'). Viral infections are associated with marrow suppression, and viruses have been implicated in hematologic syndromes like aplastic anemia (AA). 56 The genes for IFNy'h"8 and TNFO~'.~' are overexpressed in marrow and blood cells of patients with AA. TNFa mRNA is present in normal BM, in which case limited Fas expression might be implicated in normal hematopoietic cell regulation. If Fas were mainly induced by IFNy in vivo, the Fas system might be dysregulated in immune-mediated marrow disease. Increased Fas expression and decreased viability of CD34' cells has been reported in refractory anemia." Interference with the Fas antigedFas ligand system might be an attractive target of experimental therapy in marrow failure syndromes. For personal use only. on April 14, 2017. by guest www.bloodjournal.org From
